Netherlands· NL-d93f1d868a6b
Fluarix, suspensie voor injectie in een voorgevulde spuit
A influenza, inaktiviert, spalt/split virus oder oberflächen-antigen product containing a-darwin-1454-2025 (h3n2)-achtige stam (a-michigan-105-2025, san-049a) + a-missouri-11-2025 (h1n1)pdm09-achtige stam (a-switzerland-6849-2025, ivr-278) + b-tokyo-eis13-175-2025-achtige stam (b-tokyo-eis13-175-2025, wild type), registered in Netherlands by GlaxoSmithKline B.V.. The same ATC class is registered in 11 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Influenza, inaktiviert, spalt/split virus oder oberflächen-antigen is registered in 11 of 19 countries.
Countries holding a registration under ATC J07BB02 (influenza, inaktiviert, spalt/split virus oder oberflächen-antigen), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 7 of them publish a price we can compare per daily dose
Influenza, inaktiviert, spalt/split virus oder oberflächen-antigen · ATC J07BB02
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- A-DARWIN-1454-2025 (H3N2)-ACHTIGE STAM (A-MICHIGAN-105-2025, SAN-049A) + A-MISSOURI-11-2025 (H1N1)PDM09-ACHTIGE STAM (A-SWITZERLAND-6849-2025, IVR-278) + B-TOKYO-EIS13-175-2025-ACHTIGE STAM (B-TOKYO-EIS13-175-2025, wild type)
- Manufacturer
- GlaxoSmithKline B.V.
- Country
- Netherlands (NL)
- ATC code
- J07BB02
- ATC class
- Influenza, inaktiviert, Spalt/Split Virus oder Oberflächen-Antigen
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id133860
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J07BB02
Influenza, inaktiviert, spalt/split virus oder oberflächen-antigen, as other registers publish it.
- PolandAdjupanrixGlaxoSmithKline Biologicals S.A.
- DenmarkAdjupanrixGlaxoSmithKline Biologicals S.A.
- BelgiumAdjupanrixGlaxoSmithKline Biologicals
- IcelandAdjupanrixGlaxoSmithKline Biologicals S.A.*
- FinlandAdjupanrixGlaxoSmithKline Biologicals SA
- CzechiaADJUPANRIXGlaxoSmithKline Biologicals S.A., Rixensart
- IrelandAdjupanrix suspension and emulsion for emulsion for injection. Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted)GlaxoSmithKline Biologicals S.A.
- NetherlandsAdjupanrix, (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals, suspensie en emulsie voor emulsie voor injectieGlaxoSmithKline Biologicals S.A.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fed74739-048d-4cb1-b756-1147b3af7edd GET /v1/drugs/fed74739-048d-4cb1-b756-1147b3af7edd?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Suspensie voor injectie",
"route": "Intramusculair gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h133860_smpc.pdf",
"strength": null,
"atc_label": "Influenza, Purified Antigen",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg133860",
"excipients": [
"DINATRIUMWATERSTOFFOSFAAT 12-WATER (E 339)",
"KALIUMCHLORIDE (E 508)",
"KALIUMDIWATERSTOFFOSFAAT 0-WATER (E 340)",
"MAGNESIUMCHLORIDE 6-WATER (E 511)",
"NATRIUMCHLORIDE",
"OCTOXINOL 10",
"POLYSORBAAT 80 (E 433)",
"TOCOFEROL, D-ALFA WATERSTOFSUCCINAAT",
"WATER VOOR INJECTIE"
],
"substances": [
"A-DARWIN-1454-2025 (H3N2)-ACHTIGE STAM (A-MICHIGAN-105-2025, SAN-049A)",
"A-MISSOURI-11-2025 (H1N1)PDM09-ACHTIGE STAM (A-SWITZERLAND-6849-2025, IVR-278)",
"B-TOKYO-EIS13-175-2025-ACHTIGE STAM (B-TOKYO-EIS13-175-2025, wild type)"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h133860.pdf",
"authorised_at": "2025/03/03",
"procedure_number": "DE/H/4925/001",
"dispensing_status": "Uitsluitend recept",
"registration_number": "133860",
"additional_monitoring": "N"
}See everything about influenza, inaktiviert, spalt/split virus oder oberflächen-antigen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.